Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2018 DISEASE NETWORK PROJECTS LOGIN
 
 
  
Programme I -
--->News
[-]The Project
--->Sponsor
--->[-]Executive Committee
--->Arnesen
--->Blumenstein
--->Humbert
--->Jones
--->Kulisevsky
--->Mariotti
--->Muehlbaeck
--->Reilmann
--->Roos
--->Rosser
--->Weydt
--->Capper-Loup
--->Feihle
--->Levey
--->McLean
--->Public Documents
--->[+]Writing Committee Strategic ...
--->[+]Scientific and Bioethics Advis...
--->Central Coordination
--->Language Coordination
--->Fellowship Programme
--->[-]Constitution
--->Article 1
--->Article 2
--->Article 3
--->Article 4
--->Article 5
--->Article 6
--->Article 7
--->Article 8
--->Article 9
--->Article 10
--->Article 11
--->Article 12
--->Documents
--->[+]Voting/Nomination
--->[-]Members
--->Request
[-]Locations
--->[-]Austria
--->Coordination
--->HD Associations
--->Graz
--->Innsbruck
--->[+]Salzburg
--->[+]Vienna-Uni
--->[-]Belgium
--->Coordination
--->HD Associations
--->Huntington Liga
--->Ligue Huntington
--->Antwerpen
--->[+]Bierbeek
--->Brussel - VUB
--->Bruxelles - Saint-Luc
--->Bruxelles - Erasme (UCL)
--->Charleroi
--->Leuven
--->Liège (Luik)
--->[+]Czech Republic
--->[+]Denmark
--->[+]Finland
--->[+]France
--->[+]Germany
--->[+]Ireland
--->[+]Italy
--->[+]Netherlands
--->[-]Norway
--->Coordination
--->HD Associations
--->Bergen
--->Oslo
--->Trondheim
--->[+]Poland
--->[+]Portugal
--->[+]Russia
--->[-]Spain
--->Coordination
--->HD Associations
--->Alicante
--->Badajoz
--->Barcelona - Bellvitge
--->Barcelona - Clinic i Provincia...
--->Barcelona - Mutua de Terra...
--->Barcelona - Santa Creu i Sa...
--->Barcelona - Merced
--->Bilbao
--->Burgos
--->Canaries
--->Granada
--->Fuenlabrada
--->[+]Madrid-BTCIEN
--->Madrid - Clínico
--->Madrid - FJD
--->Madrid - RyC
--->Murcia
--->Oviedo
--->Palma de Mallorca
--->Pamplona
--->Santiago
--->Sevilla
--->Sevilla-HUVRocio
--->Sevilla-St-Ana
--->Valencia
--->Zaragoza
--->[+]Sweden
--->[+]Switzerland
--->[-]U.K.
--->Coordination
--->HD Associations
--->Links
--->[+]UKHDN
--->Standard of Care
--->Aberdeen
--->[+]Ayr
--->Belfast
--->Birmingham
--->[+]Blandford Forum
--->Bristol
--->Cambridge
--->Cardiff
--->Dundee
--->Edinburgh
--->Exeter
--->Fife
--->Forth Valley
--->Glasgow
--->Gloucester
--->Hull
--->Inverness
--->Launceston
--->Leeds
--->Leicester
--->Liverpool
--->London - Guy's Hospital
--->London - Hammersmith
--->London - NHNN
--->London - Royal Hospital
--->London - St. George´s
--->Manchester
--->Newcastle-Upon-Tyne
--->[+]Northampton
--->Nottingham
--->Oxford
--->[+]Plymouth
--->Poole
--->Preston
--->Reading
--->[+]Sheffield
--->Southampton
--->Stoke-on-Trent
--->Swindon
--->Wrexham
--->[+]Outside Europe
[-]Working Groups
--->[+]Advanced HD
--->[-]Behavioural Phenotype
--->Dates
--->[-]Meetings
--->Meeting 2005/06
--->Meeting 2005/09
--->Meeting 2008/09
--->Meeting 2009/03
--->Meeting 2010/03
--->Meeting 2011/05
--->[+]Psycho appr. & interv. Sub...
--->[+]Biological Modifiers
--->[+]Biomarkers
--->[+]Brain and Tissue Banking
--->[-]Cognitive Phenotype
--->[+]Dates
--->[-]Meetings
--->Meeting 2005/03
--->Meeting 2008/09
--->Meeting 2009
--->Meeting 2012
--->[+]Environmental Modifiers
--->[+]Functional Ability
--->[+]Genetic Testing
--->[+]Genetic Modifiers
--->[+]Health Economics
--->[+]Heated TF
--->[+]Imaging
--->[+]Juvenile HD
--->[+]Motor Phenotype
--->[+]Neuroprotective Therapy
--->[+]Physiotherapy
--->[+]Quality of Life
--->[+]Standard of Care
--->[-]Surgical Approaches
--->Dates
--->[-]Meetings
--->Meeting 2007/01
--->Meeting 2007/05
--->Meeting 2008/05
--->Meeting 2009/03
--->Meeting 2012
--->[+]Symptomatic Research
--->[-]Young Adults
--->[-]Dates
--->[+]Meetings
--->Members
[-]Events
--->[-]EHDN 2018
--->Announcement
--->Announcement 2020
--->Introduction
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Registration
--->Photos
--->Sponsoring/Partners
--->CME points
--->HD on the Move
--->Travel Information
--->Hotel booking
--->Flight booking
--->ACV Security Checks
--->About Vienna
--->Useful information
--->Contacts
--->Reimbursement
--->[+]Abstract Submission
--->Documents
--->Feedback
--->[+]EHDN 2016
--->EHDN 2014
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel Booking
--->Reimbursement
--->Social Activities
--->[+]Abstract Submission
--->Contacts
--->Feedback
--->[+]EHDN 2012
--->[+]EHDN 2010
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[+]EHDN 2005
--->[+]EHDN 2004
[+]Communication
--->Job Offers

Programme EHDN 2014

application/pdfehdn2014-programme 
Thursday, September 18th, 2014

16:00-22:00   Registration Desk

Friday, September 19th, 2014
07:30-08:30   Registration Desk
 
Welcome and Introduction
08:30-09:00 G. Bernhard Landwehrmeyer (Ulm, Germany)
Bea De Schepper (President of the EHA, Moerbeke-Waas, Belgium)
 
Plenary Session I:
'The Natural History Of HD'
Chair: Sarah Tabrizi (London, UK)
Co-chair: Ray Dorsey (Baltimore, USA)
 
09:00-09:20   Natural history of HD in human
Sarah Tabrizi (London, UK)
 
09:20-09:40   Natural history in animal models of HD: HD recapitulation?
Roger Barker (Cambridge, UK)
 
09:40-10:00   Enroll HD: an update on progress and future development
G. Bernhard Landwehrmeyer (Ulm, Germany)
 
10:00-10:30   Panel discussion
Ray Dorsey (Baltimore, USA)
 
10:30-11:00   Tea/Coffee Break

Plenary Session II:
'Disease Modifiers'
Chair: Lesley Jones (Cardiff, UK)
Co-chair: James Gusella (Boston, USA)
 
11:00-11:20   Genetic modifiers
Lesley Jones (Cardiff, UK)
 
11:20-11:40   Environmental modifiers
Jan Frich (Oslo, Norway)
 
11:40-12:00   Modifiers: an opportunity to test in clinical trials?
Jose Florez (Massachusetts, USA)
 
12:00-12:30   Panel discussion
 
Poster Viewing
Chairs: TBA
 
12:30-14:00   Poster Viewing & Poster Tours
 
12:30-14:00   Buffet Style Lunch
 
Parallel Session I:

Science Session:
'Targeting KMO'
Chair: Flaviano Giorgini (Leicester, UK)
Co-Chair: Cheryl Fitzer-Attas (Princeton, USA)
 
14:00-14:15   Basic understanding and gaps
Ladislav Mrzljak (Princeton, USA)
 
14:15-14:30   KMO: markers and drug development
Leticia Toledo-Sherman (Los Angeles, USA)
 
14:30-14:45   Clinical trials in perspective
Cristina Sampaio (Princeton, USA)
 
14:45-15:00   Panel discussion
 
Clinical Practice Session:
'HD diagnosis'
Chair: Alexandra Dürr (Paris, France)
Co-Chair: Karen Anderson (Baltimore, USA)
 
14:00-14:15   Genetic testing in pre-symptomatic HD
Alexandra Dürr (Paris, France)
 
14:15-14:30   Should diagnostic criteria in HD be changed?
Elizabeth McCusker (Sydney, Australia)
 
14:30-14:45   Is there a need for regular check-ups?
David Craufurd (Manchester, UK)
 
14:45-15:00   Panel discussion
 
Short Communications I:
'Scientific Presentations: 10’ and 5’ questions – selected from submissions'
Chair: Jaime Kulisevsky (Barcelona, Spain)
 
15:15-15:30   TBA
TBA
 
15:30-15:45   TBA
TBA
 
15:45-16:00   TBA
TBA
 
16:00-16:15   TBA
TBA
 
16:15-16:45   Tea/Coffee Break
 
Plenary Session III:
'Biomarkers'
Chair: Rachael Scahill (London, UK)
Co-chair: Andrew Feigin (New York, USA)
 
16:45-17:05   Reviewing progress to date in HD
Blair Leavitt (Vancouver, Canada)
 
17:05-17:25   A look at the road ahead - The challenge of biomarkers and the endpoints quest
Beth Borowsky (Princeton, USA)
 
17:25-17:45   Panel discussion
 
Roundup I: Lessons of the day
17:45-18:00   Lessons of the day
Edward Wild (London, UK) and Jeff Carroll (Bellingham, USA)
 
Evening get together
18:15-20:15   
Guided Poster Tour
 
18:30-20:00   
Meet Experts around tapas and wine
Experts and Topics TBA
 
18:30-19:45
 Film - Do you really want to know
Film - Alive and Well
 
20:15-21:30 Film - Alive and Well
Film - Do you really want to know
Programme Saturday
Programme Sunday
about us | privacy statement | disclaimer | terms of use